Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro.
Murray J, Hogan RJ, Martin DE, Blahunka K, Sancilio FD, Balyan R, Lovern M, Still R, Tripp RA. Murray J, et al. Among authors: sancilio fd. Sci Rep. 2021 Sep 10;11(1):18085. doi: 10.1038/s41598-021-97658-w. Sci Rep. 2021. PMID: 34508172 Free PMC article.
SC411 treatment can enhance survival in a mouse model of sickle cell disease.
Wu CYC, Lopez-Toledano MA, Daak AA, Clemons GA, Citadin CT, Sancilio FD, Rabinowicz AL, Minagar A, Neumann JT, Lee RHC, Lin HW. Wu CYC, et al. Among authors: sancilio fd. Prostaglandins Leukot Essent Fatty Acids. 2020 Jul;158:102110. doi: 10.1016/j.plefa.2020.102110. Epub 2020 May 3. Prostaglandins Leukot Essent Fatty Acids. 2020. PMID: 32447175 Free article.
Advanced Lipid Technologies® (ALT®): A Proven Formulation Platform to Enhance the Bioavailability of Lipophilic Compounds.
Lopez-Toledano MA, Saxena V, Legassie JD, Liu H, Ghanta A, Riseman S, Cocilova C, Daak A, Thorsteinsson T, Rabinowicz AL, Sancilio FD. Lopez-Toledano MA, et al. Among authors: sancilio fd. J Drug Deliv. 2019 Jul 8;2019:1957360. doi: 10.1155/2019/1957360. eCollection 2019. J Drug Deliv. 2019. PMID: 31360551 Free PMC article. Review.
Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3-acid ethyl esters with an Advanced Lipid TechnologiesTM (ALT®)-based formulation.
Lopez-Toledano MA, Thorsteinsson T, Daak AA, Maki KC, Johns C, Rabinowicz AL, Sancilio FD. Lopez-Toledano MA, et al. Among authors: sancilio fd. J Clin Lipidol. 2017 Mar-Apr;11(2):394-405. doi: 10.1016/j.jacl.2017.01.017. Epub 2017 Feb 9. J Clin Lipidol. 2017. PMID: 28502496 Clinical Trial.
A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid TechnologiesTM (ALT®) Improves Docosahexaenoic Acid and Eicosapentaenoic Acid Bioavailability Compared with Lovaza®.
Lopez-Toledano MA, Thorsteinsson T, Daak A, Maki KC, Johns C, Rabinowicz AL, Sancilio FD. Lopez-Toledano MA, et al. Among authors: sancilio fd. Clin Ther. 2017 Mar;39(3):581-591. doi: 10.1016/j.clinthera.2017.01.020. Epub 2017 Feb 9. Clin Ther. 2017. PMID: 28189364 Clinical Trial.
Thermally-prepared polymorphic forms of cilostazol.
Stowell GW, Behme RJ, Denton SM, Pfeiffer I, Sancilio FD, Whittall LB, Whittle RR. Stowell GW, et al. Among authors: sancilio fd. J Pharm Sci. 2002 Dec;91(12):2481-8. doi: 10.1002/jps.10240. J Pharm Sci. 2002. PMID: 12434391
13 results